Company Filing History:
1 out of 443 
1 out of 8,373 
1 out of 1,373 
Years Active: 2025
Title: Matan Hofree: Innovator in Colorectal Cancer Treatment
Introduction
Matan Hofree is a prominent inventor based in Cambridge, MA, who has made significant contributions to the field of cancer research. His innovative work focuses on predicting outcomes and developing treatment methods for colorectal cancer. With a single patent to his name, Hofree's research has the potential to transform therapeutic approaches for cancer patients.
Latest Patents
Hofree's patent, titled "Methods for predicting outcomes and treating colorectal cancer using a cell atlas," is a groundbreaking invention. This patent presents a colorectal cell atlas that offers methods for predicting cancer patient outcomes and identifying therapeutic targets. The atlas is particularly useful in predicting responses to immunotherapy, including checkpoint blockade therapy and adoptive cell transfer. The invention also reveals previously unidentified gene programs in tumors that can be utilized to predict responses and provide therapeutic targets to shift tumors to a more responsive phenotype.
Career Highlights
Throughout his career, Matan Hofree has worked with esteemed institutions such as the Broad Institute and the Massachusetts Institute of Technology (MIT). His experience in these prestigious organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Hofree has had the opportunity to work alongside notable colleagues, including Aviv Regev and Nir Hacohen. These collaborations have further enriched his research and have played a crucial role in the development of his innovative approaches to cancer treatment.
Conclusion
Matan Hofree's contributions to colorectal cancer research exemplify the impact of innovation in medicine. His patented methods and collaborative efforts position him as a key figure in the ongoing fight against cancer. The potential applications of his work could lead to improved outcomes for patients in need of effective treatments.